Cardiac - Study Guide III

1. X - Identify sources that cause a false positive Tl-201 scan. Ans

2. X - Evaluate patient prognosis based on MPI result: with and without prior MI. Ans

3. X - Evaluate MPI imaging artifacts to include, but not limited to: upward creep, breast/lateral fat attenuation, diaphragmatic attenuation, excessive GI uptake, patient motion, excessive R-waves, and dextrocardia situs inverses. Ans


4. Compare and contrast first pass to MUGA. Ans


5. Analyze first pass time activity curves to determine the presence of a shunt. Ans


6. Identify the different methods of labeling RBCs and determine which technique has the best target to background. Ans


7. Identify the different methods of gating a blood pool study (forward, reverse, timing window, and list mode) Ans


8. Calculate an EF of the LV via MUGA and first pass. Ans


9. Compare global to regional ejection fraction. Discussed in class


10. Explain the MUGA acquisition process. Ans


11. Define wall motion terms and relate to appropriate disease. Ans


12. Discuss temporal (wrap) and spatial filtering (smooth) as related to MUGA imaging. Ans


13. Define and apply phase and amplitude analysis as it related to wall motion. Ans


14. Explain the quantified images seen in a first pass procedure and determine %EF. Ans


15. Identify the pathophysiology and imaging properties of the different radiopharmaceuticals used in PET cardiology (¹⁵O, ¹³NH₃, FDG, ⁸²RB, Flurpiridaz) Ans


16. Identify cardiac protocol for FDG viability and ⁸²RB stress/rest. Ans


17. X - Discuss the PET cardiac concepts in myocardial blood flow and reserve. Ans


18. Evaluate the protocol for imaging cardiac sarcoidosis. Ans

Return to the beginning of the document
Return to the Table of Content

4/23